Carousel Test – Vycellix

[rev_slider alias="business-02-animated"]

To provide superior outcomes for patients through the delivery of highly innovative allogeneic medicines that eliminate the risk of immune rejection.

Vycellix to Provide Universal Cell Cancer Therapy Progress Reports at Upcoming Investor & Partnering Meetings
June 4, 2026